BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 27160171)

  • 1. Effects of renal sympathetic denervation on blood pressure and glycaemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry).
    Kądziela J; Prejbisz A; Kostka-Jeziorny K; Dudek D; Narkiewicz K; Sadowski J; Lekston A; Gziut A; Więcek A; Buszman P; Kleinrok A; Kochman J; Czarnecka D; Januszewicz A; Witkowski A
    Kardiol Pol; 2016; 74(9):961-8. PubMed ID: 27160171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M
    Circulation; 2013 Jul; 128(2):132-40. PubMed ID: 23780578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
    Lenski M; Mahfoud F; Razouk A; Ukena C; Lenski D; Barth C; Linz D; Laufs U; Kindermann I; Böhm M
    Int J Cardiol; 2013 Nov; 169(6):418-24. PubMed ID: 24157238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of pseudo-resistance on the effect of renal denervation on 24-hour ambulatory blood pressure levels.
    Lambert T; Nahler A; Reiter C; Gammer V; Blessberger H; Kammler J; Grund M; Saleh K; Schwarz S; Steinwender C
    Catheter Cardiovasc Interv; 2015 Sep; 86(3):E126-30. PubMed ID: 26033366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of response to renal denervation for resistant arterial hypertension: a single center experience.
    Rohla M; Nahler A; Lambert T; Reiter C; Gammer V; Grund M; Blessberger H; Kammler J; Kypta A; Saleh K; Huber K; Steinwender C; Weiss TW
    J Hypertens; 2016 Jan; 34(1):123-9. PubMed ID: 26556567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A
    Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal denervation in patients with resistant hypertension: six-month results.
    Dores H; de Sousa Almeida M; de Araújo Gonçalves P; Branco P; Gaspar A; Sousa H; Canha Gomes A; Andrade MJ; Carvalho MS; Campante Teles R; Raposo L; Mesquita Gabriel H; Pereira Machado F; Mendes M
    Rev Port Cardiol; 2014 Apr; 33(4):197-204. PubMed ID: 24472425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal denervation in hypertensive patients not on blood pressure lowering drugs.
    De Jager RL; Sanders MF; Bots ML; Lobo MD; Ewen S; Beeftink MM; Böhm M; Daemen J; Dörr O; Hering D; Mahfoud F; Nef H; Ott C; Saxena M; Schmieder RE; Schlaich MP; Spiering W; Tonino PA; Verloop WL; Vink EE; Vonken EJ; Voskuil M; Worthley SG; Blankestijn PJ
    Clin Res Cardiol; 2016 Sep; 105(9):755-62. PubMed ID: 27105858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal denervation for mild-moderate treatment-resistant hypertension : A timely intervention?
    Chen S; Kiuchi MG; Schmidt B; Hoye NA; Acou WJ; Liu S; Chun KRJ; Pürerfellner H
    Herz; 2019 Aug; 44(5):412-418. PubMed ID: 29255910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.
    Lambert T; Gammer V; Nahler A; Blessberger H; Kammler J; Grund M; Kerschner K; Buchmayr G; Saleh K; Kypta A; Hönig S; Wichert-Schmitt B; Schwarz S; Sihorsch K; Reiter C; Steinwender C
    Int J Cardiol; 2015 Feb; 181():96-101. PubMed ID: 25497527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry.
    Tsioufis C; Ziakas A; Dimitriadis K; Davlouros P; Marketou M; Kasiakogias A; Thomopoulos C; Petroglou D; Tsiachris D; Doumas M; Skalidis E; Karvounis C; Alexopoulos D; Vardas P; Kallikazaros I; Stefanadis C; Papademetriou V; Tousoulis D
    Clin Res Cardiol; 2017 May; 106(5):322-330. PubMed ID: 27957627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
    Bakris GL; Townsend RR; Liu M; Cohen SA; D'Agostino R; Flack JM; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2014 Sep; 64(11):1071-8. PubMed ID: 24858423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial.
    Oliveras A; Armario P; Clarà A; Sans-Atxer L; Vázquez S; Pascual J; De la Sierra A
    J Hypertens; 2016 Sep; 34(9):1863-71. PubMed ID: 27327441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial.
    Kandzari DE; Weber MA; Pathak A; Zidar JP; Saxena M; David SW; Schmieder RE; Janas AJ; Langer C; Persu A; Mendelsohn FO; Ameloot K; Foster M; Fischell TA; Parise H; Mahfoud F
    Circulation; 2024 Jun; 149(24):1875-1884. PubMed ID: 38587557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of local vascular lesions assessed with optical coherence tomography and ablation points on blood pressure reduction after renal denervation.
    Ghadri JR; Gaehwiler R; Jaguszewski M; Sudano I; Osipova J; Schoenenberger-Berzins R; Erne P; Lüscher TF; Templin C
    Swiss Med Wkly; 2015; 145():w14102. PubMed ID: 25658048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Account for Clinical Heterogeneity in Assessment of Catheter-based Renal Denervation among Resistant Hypertension Patients: Subgroup Meta-analysis.
    Chen XH; Kim S; Zeng XX; Chen ZB; Cui TL; Hu ZX; Li Y; Fu P
    Chin Med J (Engl); 2017 Jul; 130(13):1586-1594. PubMed ID: 28639575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of renal denervation on resistant hypertension: Meta-analysis of randomized controlled clinical trials.
    Yao Y; Zhang D; Qian J; Deng S; Huang Y; Huang J
    Clin Exp Hypertens; 2016; 38(3):278-86. PubMed ID: 27018652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal sympathetic denervation in Sweden: a report from the Swedish registry for renal denervation.
    Völz S; Spaak J; Elf J; Jägrén C; Lundin C; Stenborg A; Andersson J; Rundqvist B; Kahan T; Andersson B
    J Hypertens; 2018 Jan; 36(1):151-158. PubMed ID: 29210862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistant hypertension: Renal denervation or pharmacovigilance? Insights from a renal denervation screening program.
    Ojrzanowski M; Kasprzak JD; Peruga JZ; Kurpesa M; Jankowski Ł; Sahni S; Plewka M
    Adv Clin Exp Med; 2019 Nov; 28(11):1525-1530. PubMed ID: 31693316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.